MedTrace Logo

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

NCT02399306 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2020-03-17

No results posted yet for this study

Summary

This is a randomized, prospective, multicenter study.

Conditions

Interventions

DRUG

Enteral nutrition

Patients in the Trial Group received concurrent chemoradiotherapy and standardized, whole-course enteral nutrition management.

RADIATION

radiotherapy

Patients receive intensity modulated radiation therapy(IMRT) from week 1 to week 7,once a day, 5 times per week. Radiotherapy dose：95% gross tumor volume（GTV-T） 60-66 Gy /30-33f，GTV-N 60-66 Gy /30-33f，CTV-T 50-54 Gy /25-27f，CTV-N 50-54 Gy /25-27f.

Sponsors & Collaborators

  • Wuhan University

    collaborator OTHER

  • Xiangya Hospital of Central South University

    collaborator OTHER

  • Shanxi Province Cancer Hospital

    collaborator OTHER

  • Shandong Tumor Hospital

    collaborator OTHER

  • Henan Cancer Hospital

    collaborator OTHER_GOV

  • Peking University Cancer Hospital & Institute

    collaborator OTHER

  • Hebei Medical University Fourth Hospital

    collaborator OTHER

  • Sichuan Cancer Hospital and Research Institute

    lead OTHER

Principal Investigators

  • TAO LI, MD, PhD · Sichuan Cancer Hospital and Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02399306 on ClinicalTrials.gov